Ibogaine was recently cleared for clinical trials, though it remains off limits in the U.S. Experts say it isn't like other ...

On April 18, 2026, President Donald Trump signed an executive order and announced a federal investment of millions of dollars in ibogaine research. He also directed the FDA to accelerate its review of ...

For the first time in more than 50 years, The Department of Veterans Affairs announced this month that it would fund research into psychedelic therapies. Their decision may be in response to the ...

Psychedelic drugs, once pushed to the fringes of medicine, are gaining serious attention within the Trump administration as potential treatment options for people with certain mental health conditions ...

By Jenny Gonzales For generations, the Bwiti religion in Gabon has revered ibogaine, a powerful psychedelic alkaloid ...

Ibogaine—a psychoactive plant derivative—has attracted attention for its anti-addictive and anti-depressant properties. But ibogaine is a finite resource, extracted from plants native to Africa like ...

Ibogaine is a plant-derived psychedelic medication that is illegal in the U.S. and many other countries. It causes hallucinations that can last more than 24 hours and cause cardiac problems. Studies ...

A recent executive order directing federal agencies to accelerate research pathways for psychedelic drugs named only one compound specifically by name: ibogaine. The announcement was framed as the ...

President Donald Trump on Saturday signed an executive order aimed at encouraging expanded research into psychedelic drugs, part of a broader push to explore emerging mental health treatments. “In ...

For military veterans, many of the deepest wounds of war are invisible: Traumatic brain injuries resulting from head trauma or blast explosions are a leading cause of post-traumatic stress disorder, ...